Monographie - Amsacrine - Stabilis 4.0

Poslední aktualizace :
19/11/2024

rakovina drog

Amsacrine

injekce

Stabilita roztoků

Stabilita směsí

Faktory ovlivňující stabilitu

Kompatibilita

Způsoby aplikace

Odkazy

pdf

Chemický vzorec

Obchodní název

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amekrin	Dánsko, Finsko, Norsko, Švédsko
Amsa PD	Kanada
Amsalyo	Francie
Amsidine	Austrálie, Belgie, Itálie, Nizozemsko
Amsidyl	NÏmecko, Švýcarsko

Odkazy

injekce

Odkazy : Amsacrine

	typ	uveřejnění
182	noviny	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
253	noviny	Trissel LA, Chandler SW, Folstad JT. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1990 ; 47: 2525-2528.
334	noviny	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	noviny	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
492	noviny	Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189.
829	noviny	Cartwright-Shamoon JM, McElnay JC, D'Arcy PF. Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets. Int J Pharm 1988 ; 42: 41-46.
3523	Laboratoř	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3576	Laboratoř	Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit Prostrakan 2012
3595	Laboratoř	Aciclovir - Summary of Product Characteristics Hospira 2009
3745	noviny	Kuenhle C, Moore Sodium chloride residue provides potential for drug incompatibiities. Am J Hosp Pharm 1979 ; 36: 881.

Mentions Légales